Regenerative Medical Technology (RMTG) Notes Payables (2017 - 2025)
Historic Notes Payables for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to $1.2 million.
- Regenerative Medical Technology's Notes Payables fell 9336.42% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 9336.42%. This contributed to the annual value of $17.7 million for FY2024, which is 64383.34% up from last year.
- Per Regenerative Medical Technology's latest filing, its Notes Payables stood at $1.2 million for Q3 2025, which was down 9336.42% from $17.7 million recorded in Q2 2025.
- In the past 5 years, Regenerative Medical Technology's Notes Payables registered a high of $19.7 million during Q2 2024, and its lowest value of $1.2 million during Q3 2025.
- Moreover, its 5-year median value for Notes Payables was $15.1 million (2022), whereas its average is $13.6 million.
- As far as peak fluctuations go, Regenerative Medical Technology's Notes Payables surged by 64383.34% in 2024, and later crashed by 9336.42% in 2025.
- Regenerative Medical Technology's Notes Payables (Quarter) stood at $13.3 million in 2021, then grew by 12.99% to $15.1 million in 2022, then crashed by 84.19% to $2.4 million in 2023, then surged by 643.83% to $17.7 million in 2024, then crashed by 93.51% to $1.2 million in 2025.
- Its Notes Payables was $1.2 million in Q3 2025, compared to $17.7 million in Q2 2025 and $17.7 million in Q1 2025.